Bolivia Medical Device Registration Rectification and Adding Items: Manual Section 5.10.2

1. Key takeaways

Section 5.10.2 of the Manual allows items to be added to an existing sanitary registration through a rectificación, but with one hard condition: the added items must belong to the same risk class and the same group as the original registration. The GRZAN decision flow has three steps. First determine the group, checking whether the new items fall within the same group of Anexo 2 as the original registration. Then determine the class, confirming that the risk class is identical. If both match, the rectification route applies; if either differs, a new application is required. This rule gives the initial group selection a long-term cost implication, because the choice made at first registration determines whether every future line extension can use the economical correction path or must return to a full new application with its associated fees and review time.

The arithmetic is easiest to see at portfolio level. Under the practical estimate used by GRZAN, a product line that stays inside one group and one class can grow item by item through rectifications, each requiring far less preparation than a fresh dossier, while a line that straddles groups splits into separate registrations from the outset. The mapping table recommended below is therefore not an administrative nicety but the instrument that makes the routing decision visible before money is spent. Product managers should be able to answer, for any SKU on the roadmap, whether it inherits the existing certificate boundary or opens a new one, and that answer should exist before the development plan is approved rather than after the first unit is built.

2. Legal basis

3. Expert insights

Insight one: the rectification path is a cost optimization tool, not a universal channel. Its applicability is strictly confined by the same-group, same-class condition. A company that assumes it can register one product first and add the rest of the portfolio later will be forced back into new applications whenever a cross-group or cross-class item appears, and the cost advantage disappears entirely. The correct mental model is to treat rectification as a discount available only inside the boundary drawn at first registration, and to price portfolio decisions against that boundary.

Insight two: the self-declared nature of the risk class makes the same-class test uncertain. The class is declared by the applicant under Section 1.7 and Section 2.4.7. If the declared class of the new item differs from the declared class of the registered item, the rectification route is closed even where the products are functionally similar. This reinforces a broader lesson: the classification rationale should be built to be reusable at the first registration, with documented reasoning that can be applied consistently to successor products, so that future additions inherit the same class by argument rather than by chance. A classification file that cites the intended use, the duration of contact, and the applicable rule of Anexo 2 for the anchor product can be extended to successors line by line, and each new declaration then stands on recorded reasoning that a reviewer can follow without guessing.

Insight three: rectification and change of registration are not the same thing. Section 5.10.2 addresses adding items to an existing registration. Matters such as a change of manufacturer name, a change of address, or a rebranding are a different category, and public sources do not yet show unified detailed rules for them. GRZAN lists these as pending verification items and does not offer speculative conclusions. Treating a name change as if it were a simple rectification, without written confirmation, is the kind of assumption that produces an invalid certificate and a blocked shipment. The safe posture is to log every non-addition change request in a separate register with its own confirmation status, so that the rectification file stays clean and the open questions stay visible until AGEMED answers them.

4. Practical recommendations

1. Cover the three-to-five-year product roadmap in the first registration, so that subsequent launches have room to use the rectification path instead of requiring separate new applications with their full fees and timelines.
2. Build a SKU-to-group-to-class mapping table and place it under change management, rerunning the group and class test after every product iteration so that the routing decision is always current and documented.
3. Confirm the route for change-type matters, such as name, address, or brand, with AGEMED separately, and never fold them into the item-addition process, keeping each pathway and its evidence file distinct.

A brief illustration makes the sequencing concrete. Consider a company whose first registration covers a Class II vital-signs monitor in one group of Anexo 2. A Year 2 accessory that belongs to the same group and class can follow through a rectification, with modest preparation and no new group analysis. A Year 3 defibrillator, whatever its merits, opens a different boundary and must be priced and planned as a new application from the start. Because the roadmap was checked against the mapping table at budget time, neither event surprises the finance plan. The failure case is the mirror image: the accessory is assumed to be an easy addition, the defibrillator is assumed to ride along, and both assumptions surface as budget overruns after commitments have been made to distributors.

5. Verification checklist

• □ Do the added items fall within the same group of Anexo 2 as the original registration?
• □ Is the risk class of the added items identical to that of the original registration?
• □ Where group and class match, has the rectification route been confirmed as available?
• □ Where the group or class differs, has a new application been budgeted accordingly?
• □ Has the route for change-type matters such as name, address, or brand been confirmed separately?

Regulatory information verified as of October 29, 2026.

GRZAN supports medical device manufacturers, importers, and authorized representatives with sanitary registration, rectifications, and post-market compliance in Bolivia. For assistance with this topic, contact info@grzanglobal.com.